Edwards Lifesciences LLC

Edwards Lifesciences is a global cardiovascular medical device company headquartered in Irvine, California. The company designs, manufactures, and markets innovative technologies for treating cardiovascular disease, including transcatheter heart valves (aortic and mitral), surgical valve technologies, and implantable heart failure management systems. Product portfolio includes the SAPIEN transcatheter heart valve platform, PASCAL mitral and tricuspid technologies, surgical valve solutions, and PAP-guided therapy for heart failure management. Edwards operates in transcatheter valve replacement and repair, surgical heart valve replacement, and hemodynamic monitoring for critical care. The company serves hospitals, catheterization laboratories, and surgical centers worldwide. Edwards Lifesciences maintains FDA clearances and regulatory approvals across major markets. The company previously operated a Critical Care division focused on monitoring systems, which was divested to BD (Becton, Dickinson and Company). Edwards is recognized as a leader in minimally invasive cardiovascular interventions and structural heart disease management.